Stocks and Investing Stocks and Investing
Thu, April 22, 2021
Wed, April 21, 2021

Gena Wang Maintained (VRTX) at Buy and Held Target at $302 on, Apr 21st, 2021


Published on 2024-10-27 16:20:06 - WOPRAI, Gena Wang
  Print publication without navigation


Gena Wang of Barclays, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy and Held Target at $302 on, Apr 21st, 2021.

Gena has made no other calls on VRTX in the last 4 months.



There are 7 other peers that have a rating on VRTX. Out of the 7 peers that are also analyzing VRTX, 2 agree with Gena's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $253 on, Monday, April 19th, 2021
  • Geoffrey Porges of "SVB Leerink" Maintained at Hold with Decreased Target to $250 on, Tuesday, February 2nd, 2021


These are the ratings of the 5 analyists that currently disagree with Gena


  • Brian Skorney of "Baird" Maintained at Buy and Held Target at $252 on, Tuesday, April 20th, 2021
  • Brian Abrahams of "RBC Capital" Maintained at Buy and Held Target at $265 on, Friday, April 16th, 2021
  • Do Kim of "BMO Capital" Maintained at Buy with Decreased Target to $284 on, Tuesday, February 2nd, 2021
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $347 on, Tuesday, February 2nd, 2021
  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $280 on, Tuesday, February 2nd, 2021
Contributing Sources